Research Article
Effectiveness of an Inpatient Movement Disorders Program for Patients with Atypical Parkinsonism
Table 1
Patient baseline characteristics.
| Characteristic | |
| Age—y, mean (SD) | 76.6 (7.7) | Disease duration—y, mean (SD) | 5.7 (4.4) | Sex no. (%) men/women | 53 (58.2)/38 (41.8) | Race no. (%) white | 84 (92.3) | Education no. (%) ≤ bachelor’s/>bachelor’s | 51 (56)/24 (26.4) | Hoehn and Yahr stage no. (%) | | I | 0 (0) | II | 0 (0) | III | 26 (28.6) | IV | 43 (47.3) | V | 16 (17.6) | Length of stay—d, mean (SD) | 24.4 (11.9) |
| Diagnosis no. (%) a | | Vascular parkinsonism | 25 (27.5) | MSA | 19 (20.9) | PSP | 4 (4.4) | Medication related | 2 (2.2) | LBD | 1 (1.1) | CBD | 1 (1.1) | Toxin | 1 (1.1) | Unknown | 38 (41.8) |
|
|
aMSA: multiple system atrophy, PSP: progressive supranuclear palsy, LBD: Lewy body dementia, and CBD: corticobasal dementia.
|